A retrospective descriptive study characterizing coronavirus disease epidemiology among people in the Kurdistan Region, Iraq
Characterization of COVID-19 in Kurdistan Region, Iraq
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Accepted: August 3, 2020
Authors
Abstract
On March 1, 2020, the first case of severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2) infection was diagnosed in the Kurdistan Region of Northern Iraq. The highest number of infections was recorded in Erbil city (233 cases) and Sulaymaniyah (178 cases). Among diagnosed patients, 20% had symptoms. The most common symptoms were fever (9.5%), dry cough (12%), and shortness of breath (6.5%). There was a sharp marked increase in the number of cases after relaxing of the control measures on May 1. The case fatality rate was 1.1% (5/452). Case fatality was significantly associated with advanced age (p=0.001) but not sex (p=0.68). Overall, 385/452 patients (85.2%) recovered without complications. Most patients were asymptomatic. The case fatality rate was low but increased with age. Further research is needed to determine the high recovery and low case fatality rates relative to those reported in other countries.
Downloads
Citations
2. WHO (2020) Rolling updates on coronavirus disease (COVID-19).
3. Chen N, Zhou M, Dong X, Qu J, Gong F, et al. (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395: 507-513.
4. Wang D, Hu B, Hu C, Zhu F, Liu X, et al. (2020) Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Jama.
5. Kolifarhood G, Aghaali M, Mozafar Saadati H, Taherpour N, Rahimi S, et al. (2020) Epidemiological and Clinical Aspects of COVID-19; a Narrative Review. Archives of academic emergency medicine 8: e41-e41.
6. Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, et al. (2017) Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection. Journal of immunology (Baltimore, Md : 1950) 198: 4046-4053.
7. Khafaie MA, Rahim F (2020) Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2. Osong public health and research perspectives 11: 74-80.
8. Wu Z, McGoogan JM (2020) Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72?314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 323: 1239-1242.
9. Odone A, Delmonte D, Scognamiglio T, Signorelli C (2020) COVID-19 deaths in Lombardy, Italy: data in context. The Lancet Public Health.
10. Stafford N (2020) Covid-19: Why Germany’s case fatality rate seems so low. BMJ 369: m1395.
11. Adhikari SP, Meng S, Wu Y-J, Mao Y-P, Ye R-X, et al. (2020) Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infectious Diseases of Poverty 9: 29.
12. Hussein NR (2020) Possible Factors Associated with Low Case Fatality Rate of COVID-19 in Kurdistan Region, Iraq. Journal of Kermanshah University of Medical Sciences 24: e103393.
13. Hussein NR, Naqid IA, Saleem ZSM, Musa DH, Ibrahim N (2020) The Impact of Breaching Lockdown on the Spread of COVID-19 in Kurdistan Region, Iraq. Avicenna J Clin Microbiol Infect 7: 34-35.
